Cargando…
Development and Validation of a Nomogram for Predicting Generalization in Patients With Ocular Myasthenia Gravis
BACKGROUND: This study aims to develop and validate a nomogram for predicting 1- and 2-year generalization probabilities in patients with ocular myasthenia gravis (OMG). METHODS: In total, 501 eligible patients with OMG treated at seven tertiary hospitals in China between January 2015 and May 2019 w...
Autores principales: | Ruan, Zhe, Sun, Chao, Lang, Yanlin, Gao, Feng, Guo, Rongjing, Xu, Quan, Yu, Liping, Wu, Songdi, Lei, Tao, Liu, Yu, Zhang, Min, Li, Huanhuan, Tang, Yonglan, Gao, Ting, Gao, Yanwu, Lu, Xiaodan, Li, Zhuyi, Chang, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302474/ https://www.ncbi.nlm.nih.gov/pubmed/35874731 http://dx.doi.org/10.3389/fimmu.2022.895007 |
Ejemplares similares
-
Melatonin exerts immunoregulatory effects by balancing peripheral effector and regulatory T helper cells in myasthenia gravis
por: Chang, Ting, et al.
Publicado: (2020) -
Do early prednisolone and other immunosuppressant therapies prevent
generalization in ocular myasthenia gravis in Western populations: a systematic
review and meta-analysis
por: Li, Mingxia, et al.
Publicado: (2019) -
Landscape analysis of m6A modification regulators related biological functions and immune characteristics in myasthenia gravis
por: Li, Shuang, et al.
Publicado: (2023) -
Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis
por: Su, Yue, et al.
Publicado: (2022) -
COVID-19 Vaccination in Patients with Myasthenia Gravis: A Single-Center Case Series
por: Ruan, Zhe, et al.
Publicado: (2021)